EXEL
NASDAQ · Biotechnology
Exelixis Inc
$41.57
+0.16 (+0.39%)
Performance
1D
—
1W
—
1M
—
3M
-10.10%
6M
+6.48%
1Y
+10.24%
YTD
-4.61%
Open$41.16
Previous Close$41.41
Day High$41.86
Day Low$40.84
52W High$49.62
52W Low$32.38
Volume—
Avg Volume3.60M
Market Cap10.72B
P/E Ratio13.70
EPS$2.78
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$43.59
Below
SMA 200
$41.49
Above
RSI (14)
62
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
27 analysts
Price Target
+179.3% upside
Current
$41.57
$41.57
Target
$116.10
$116.10
$78.53
$116.10 avg
$123.77
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.12B | 1.88B | 2.68B |
| Net Income | 716.46M | 570.98M | -77,688,294 |
| Profit Margin | 33.7% | 32.0% | -2.9% |
| EBITDA | 824.94M | 693.96M | -84,355,918 |
| Free Cash Flow | — | — | -70,301,392 |
| Rev Growth | +12.9% | +12.9% | +9.9% |
| Debt/Equity | — | — | 0.16 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |